Effect of dofetilide in patients with recent myocardial infarction and left-ventricular dysfunction: a randomised trial

L Køber, PEB Thomsen, M Møller, C Torp-Pedersen… - The Lancet, 2000 - thelancet.com
Background Arrhythmias cause much morbidity and mortality after myocardial infarction, but
in previous trials, antiarrhythmic drug therapy has not been convincingly effective. Dofetilide …

Effect of dofetilide in patients with recent myocardial infarction and left-ventricular dysfunction: a randomised trial

L Køber, PEB Thomsen, M Møller, C Torp-Pedersen… - The Lancet, 2000 - Elsevier
BACKGROUND: Arrhythmias cause much morbidity and mortality after myocardial infarction,
but in previous trials, antiarrhythmic drug therapy has not been convincingly effective …

[引用][C] Effect of dofetilide in patients with recent myocardial infarction and left ventricular dysfunction: A randomiset trial

L Køber, PEB Thomsen, M Møller… - …, 2000 - findresearchersdu.elsevierpure.com
Effect of dofetilide in patients with recent myocardial infarction and left ventricular dysfunction: A
randomiset trial — Syddansk Universitet Spring til hovednavigation Spring til søgning Spring til …

Effect of dofetilide in patients with recent myocardial infarction and left-ventricular dysfunction: a randomised trial.

L Kober, PEB Thomsen, M Moller - The Lancet, 2000 - elibrary.ru
Investigates the effectiveness of dofetilide in reducing all-cause mortality and morbidity in
patients with left-ventricular dysfunction after myocardial infarction. Methods; Findings; …

Effect of dofetilide in patients with recent myocardial infarction and left-ventricular dysfunction: a randomised trial

L Køber, PEB Thomsen, M Møller, C Torp-Pedersen… - The Lancet, 2000 - thelancet.com
Background Arrhythmias cause much morbidity and mortality after myocardial infarction, but
in previous trials, antiarrhythmic drug therapy has not been convincingly effective. Dofetilide …

[引用][C] Effect of dofetilide in patients with recent myocardial infarction and left ventricular dysfunction: A randomiset trial

L Køber, PEB Thomsen, M Møller… - …, 2000 - portal.findresearcher.sdu.dk
Effect of dofetilide in patients with recent myocardial infarction and left ventricular dysfunction:
A randomiset trial — University of Southern Denmark Skip to main navigation Skip to search …

Effect of dofetilide in patients with recent myocardial infarction and left-ventricular dysfunction: a randomised trial

L Køber, PEB Thomsen, M Møller, C Torp-Pedersen… - The Lancet, 2000 - infona.pl
Arrhythmias cause much morbidity and mortality after myocardial infarction, but in previous
trials, antiarrhythmic drug therapy has not been convincingly effective. Dofetilide, a new …

Effect of dofetilide in patients with recent myocardial infarction and left-ventricular dysfunction: a randomised trial

L Køber, PEB Thomsen, M Møller… - Lancet (London …, 2000 - pubmed.ncbi.nlm.nih.gov
Background Arrhythmias cause much morbidity and mortality after myocardial infarction, but
in previous trials, antiarrhythmic drug therapy has not been convincingly effective. Dofetilide …

Effect of dofetilide in patients with recent myocardial infarction and left-ventricular dysfunction: a randomised trial.

L Køber, BT PE, M Møller, C Torp-Pedersen… - Lancet (London …, 2000 - europepmc.org
Background Arrhythmias cause much morbidity and mortality after myocardial infarction, but
in previous trials, antiarrhythmic drug therapy has not been convincingly effective. Dofetilide …

[引用][C] Effect of dofetilide in patients with recent myocardial infarction and left-ventricular dysfunction: a randomised trial

LV Køber, PEB Thomsen, M Møller, CT Torp-Pedersen… - cfs.ku.dk
BACKGROUND: Arrhythmias cause much morbidity and mortality after myocardial infarction,
but in previous trials, antiarrhythmic drug therapy has not been convincingly effective …